ATAZANAVIR ALPHAPHARM atazanavir (as sulfate) 200 mg capsule bottle
देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
सार्वजनिक आकलन रिपोर्ट
(PAR)
18-05-2019
अनुरोध भेजा।
सक्रिय संघटक:
atazanavir sulfate, Quantity: 227.8 mg (Equivalent: atazanavir, Qty 200 mg)
थमां उपलब्ध:
Alphapharm Pty Ltd
फार्मास्यूटिकल फॉर्म:
Capsule
रचना:
Excipient Ingredients: lactose monohydrate; crospovidone; magnesium stearate; titanium dioxide; brilliant blue FCF; purified water; erythrosine; Gelatin; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide
प्रशासन का मार्ग:
Oral
पैकेज में यूनिट:
60
प्रिस्क्रिप्शन प्रकार:
(S4) Prescription Only Medicine
चिकित्सीय संकेत:
Atazanavir is indicated for the treatment of HIV 1 infection, in combination with other antiretroviral agents. This indication is based on analyses of plasma HIV-1 RNA levels and CD4 cell counts from controlled studies (see CLINICAL TRIALS).
उत्पाद समीक्षा:
Visual Identification: No.0, blue opaque cap and greenish-blue opaque body, hard-shell gelatin capsule filled with white to pale yellow powder. The capsule is axially printed with MYLAN over AR200 in black ink on both the cap and body.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
प्राधिकरण का दर्जा:
Registered
प्राधिकरण की तारीख:
2018-08-28
